» Authors » Vivi Miriagou

Vivi Miriagou

Explore the profile of Vivi Miriagou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 62
Citations 1236
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Pilato V, Pollini S, Miriagou V, Rossolini G, DAndrea M
Expert Rev Anti Infect Ther . 2024 Jan; 22(1-3):25-43. PMID: 38236906
Introduction: is a major agent of healthcare-associated infections and a cause of some community-acquired infections, including severe bacteremic infections associated with metastatic abscesses in liver and other organs. Clinical relevance...
2.
Tsilipounidaki K, Gkountinoudis C, Florou Z, Fthenakis G, Miriagou V, Petinaki E
Microorganisms . 2023 Oct; 11(10). PMID: 37894246
The objective of the present study is to report the detection and the molecular characterization of nine -positive isolates, which were isolated from patients in a tertiary care hospital in...
3.
Tsilipounidaki K, Gkountinoudis C, Florou Z, Fthenakis G, Miriagou V, Petinaki E
Microorganisms . 2023 Sep; 11(9). PMID: 37764003
The objective of the present study is to report the detection and the molecular characterization of nine -positive isolates, all of which belonged to the epidemic high-risk international clone ST308,...
4.
Agnes M, Kasimati E, Inclan M, Thanassoulas A, Miliotis G, Malanga M, et al.
Carbohydr Polym . 2023 Sep; 321:121323. PMID: 37739545
Highly resistant bacteria producing metallo-β-lactamases (MBLs) to evade β-lactam antibiotics, constitute a major cause of life-threatening infections world-wide. MBLs exert their hydrolytic action via Zn cations in their active center....
5.
Dioli C, Pappa O, Siatravani E, Bratakou S, Tatsiopoulos A, Giakkoupi P, et al.
Microorganisms . 2023 Jun; 11(6). PMID: 37374900
Antibiotic-resistant bacteria (ARB) are present in wastewaters as their elimination during treatment in wastewater treatment plants (WWTPs) is often impossible. Water plays an important role in the spread of these...
6.
Tsilipounidaki K, Florou Z, Skoulakis A, Fthenakis G, Miriagou V, Petinaki E
Microorganisms . 2023 Feb; 11(2). PMID: 36838481
The objective of the present study was to genetically characterize ten NDM-1 producing isolates, recovered from patients in a hospital in Central Greece during the period 2017 to 2021.The isolates...
7.
Kotsakis S, Lambropoulou A, Miliotis G, Tzelepi E, Miriagou V, Tzouvelekis L
Microbiol Spectr . 2022 Jul; 10(4):e0093822. PMID: 35852323
In the absence of a molecule that would collectively inhibit both metallo-β-lactamases and serine-reactive carbapenemases, containment of their genes is the main weapon currently available for confronting carbapenem resistance in...
8.
Tsilipounidaki K, Athanasakopoulou Z, Billinis C, Miriagou V, Petinaki E
Microb Drug Resist . 2021 Dec; 28(3):386-387. PMID: 34935518
No abstract available.
9.
Kotsakis S, Miliotis G, Tzelepi E, Tzouvelekis L, Miriagou V
Sci Rep . 2021 Jun; 11(1):12061. PMID: 34103596
The timely and accurate detection of carbapenemase-producing Enterobacterales (CPE) is imperative to manage this worldwide problem in an effective fashion. Herein we addressed the question of whether the protons produced...
10.
Benmimoun B, Papastefanaki F, Perichon B, Segklia K, Roby N, Miriagou V, et al.
Nat Commun . 2020 Dec; 11(1):6106. PMID: 33257684
Pathogens able to cross the blood-brain barrier (BBB) induce long-term neurological sequelae and death. Understanding how neurotropic pathogens bypass this strong physiological barrier is a prerequisite to devise therapeutic strategies....